{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:33:40Z","timestamp":1779114820311,"version":"3.51.4"},"reference-count":47,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,2,1]]},"DOI":"10.1097\/qai.0b013e31802bb5d0","type":"journal-article","created":{"date-parts":[[2006,11,22]],"date-time":"2006-11-22T18:59:54Z","timestamp":1164221994000},"page":"167-173","source":"Crossref","is-referenced-by-count":54,"title":["Prognosis of AIDS-Related Systemic Non-Hodgkin Lymphoma Treated With Chemotherapy and Highly Active Antiretroviral Therapy Depends Exclusively on Tumor-Related Factors"],"prefix":"10.1097","volume":"44","author":[{"given":"Pilar","family":"Miralles","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Berenguer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 Mar\u00eda","family":"Ribera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rubio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Mahillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Jes\u00fas","family":"T\u00e9llez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Lacruz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eulalia","family":"Valencia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jes\u00fas","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Rodr\u00edguez-Arrondo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vicente","family":"Pintado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-7-20210131","doi-asserted-by":"crossref","first-page":"402","DOI":"10.7326\/0003-4819-103-3-402","article-title":"Revision of the case definition of acquired immunodeficiency syndrome for national reporting-United States.","volume":"103","year":"1985","journal-title":"Ann Intern Med"},{"key":"R2-7-20210131","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1038\/bjc.1992.384","article-title":"The epidemiology of AIDS-associated non-Hodgkins lymphoma in the World Health Organization European Region.","volume":"66","author":"Serraino","year":"1992","journal-title":"Br J Cancer"},{"key":"R3-7-20210131","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1093\/jnci\/86.22.1711","article-title":"Cancer incidence in a population with a high prevalence of infection with human immunodeficiency virus type 1.","volume":"86","author":"Rabkin","year":"1994","journal-title":"J Natl Cancer Inst"},{"key":"R4-7-20210131","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators.","volume":"338","author":"Palella","year":"1998","journal-title":"N Engl J Med"},{"issue":"Suppl 1","key":"R5-7-20210131","first-page":"S11","article-title":"Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult\/Adolescent Spectrum of HIV Disease Project Group.","volume":"21","author":"Jones","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R6-7-20210131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1136\/bmj.319.7201.23","article-title":"Risk of HIV related Kaposis sarcoma and non-Hodgkins lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study.","volume":"319","author":"Ledergerber","year":"1999","journal-title":"BMJ"},{"key":"R7-7-20210131","doi-asserted-by":"crossref","first-page":"A39","DOI":"10.1097\/00042560-199804010-00126","article-title":"Impact of highly effective antiretroviral therapy on the incidence of malignancies among HIV infected individuals [abstract S35].","volume":"17","author":"Jacobson","year":"1998","journal-title":"J Acquir Immune Defic Syndr Hum Retrovirol"},{"key":"R8-7-20210131","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0140-6736(00)02504-6","article-title":"AIDS across Europe, 1994-98: the EuroSIDA study.","volume":"356","author":"Mocroft","year":"2000","journal-title":"Lancet"},{"issue":"Suppl 1","key":"R9-7-20210131","first-page":"S31","article-title":"Kaposis sarcoma and non-Hodgkins lymphoma incidence trends in AIDS Clinical Trial Group study participants.","volume":"21","author":"Rabkin","year":"1999","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R10-7-20210131","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/00126334-200204010-00010","article-title":"Impact of highly active antiretroviral therapy on individual AIDS-defining illness incidence and survival in Australia.","volume":"29","author":"Dore","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R11-7-20210131","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy.","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"R12-7-20210131","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1093\/jnci\/92.22.1823","article-title":"Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults.","volume":"92","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"R13-7-20210131","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy.","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"R14-7-20210131","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1200\/JCO.1991.9.6.929","article-title":"Clinical and virologic effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients receiving chemotherapy for human immunodeficiency virus-associated non-Hodgkins lymphoma: results of a randomized trial.","volume":"9","author":"Kaplan","year":"1991","journal-title":"J Clin Oncol"},{"key":"R15-7-20210131","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-108-5-744","article-title":"Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986).","volume":"108","author":"Knowles","year":"1988","journal-title":"Ann Intern Med"},{"key":"R16-7-20210131","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1002\/1097-0142(19880601)61:11<2325::AID-CNCR2820611130>3.0.CO;2-0","article-title":"AIDS-related lymphoid neoplasia. The Memorial Hospital experience.","volume":"61","author":"Lowenthal","year":"1988","journal-title":"Cancer"},{"key":"R17-7-20210131","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/jama.1989.03420050069041","article-title":"AIDS-associated non-Hodgkins lymphoma in San Francisco.","volume":"261","author":"Kaplan","year":"1989","journal-title":"JAMA"},{"key":"R18-7-20210131","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1056\/NEJM199706053362304","article-title":"Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkins lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group.","volume":"336","author":"Kaplan","year":"1997","journal-title":"N Engl J Med"},{"key":"R19-7-20210131","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1097\/00002030-199904160-00018","article-title":"HIV-associated non-Hodgkins lymphoma: highly active antiretroviral therapy improves remission rate of chemotherapy.","volume":"13","author":"Evison","year":"1999","journal-title":"AIDS"},{"key":"R20-7-20210131","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1097\/00002030-200307040-00013","article-title":"Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma.","volume":"17","author":"Hoffmann","year":"2003","journal-title":"AIDS"},{"key":"R21-7-20210131","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1089\/aid.2005.21.214","article-title":"Beneficial effect of highly active antiretroviral therapy on the prognosis of AIDS-related systemic non-Hodgkin lymphomas.","volume":"21","author":"Lascaux","year":"2005","journal-title":"AIDS Res Hum Retroviruses"},{"key":"R22-7-20210131","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1046\/j.1365-2141.2001.02656.x","article-title":"Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkins lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone.","volume":"112","author":"Navarro","year":"2001","journal-title":"Br J Haematol"},{"key":"R23-7-20210131","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood-2004-08-3300","article-title":"Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.","volume":"105","author":"Spina","year":"2005","journal-title":"Blood"},{"key":"R24-7-20210131","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/1097-0142(20010101)91:1<155::AID-CNCR20>3.0.CO;2-B","article-title":"Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma.","volume":"91","author":"Vaccher","year":"2001","journal-title":"Cancer"},{"key":"R25-7-20210131","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.1200\/JCO.1999.17.12.3835","article-title":"World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.","volume":"17","author":"Harris","year":"1999","journal-title":"J Clin Oncol"},{"key":"R26-7-20210131","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1056\/NEJM199309303291402","article-title":"A predictive model for aggressive non-Hodgkins lymphoma.","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"R28-7-20210131","doi-asserted-by":"crossref","first-page":"8477","DOI":"10.1200\/JCO.2005.02.9355","article-title":"Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy.","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"R29-7-20210131","doi-asserted-by":"crossref","first-page":"265","DOI":"10.7326\/0003-4819-143-4-200508160-00007","article-title":"A prognostic index for systemic AIDS-related non-Hodgkin lymphoma treated in the era of highly active antiretroviral therapy.","volume":"143","author":"Bower","year":"2005","journal-title":"Ann Intern Med"},{"key":"R30-7-20210131","doi-asserted-by":"crossref","first-page":"5027","DOI":"10.1200\/JCO.2005.09.137","article-title":"Introduction of combined CHOP plus rituximab therapy dramatically improved outcome of diffuse large B-cell lymphoma in British Columbia.","volume":"23","author":"Sehn","year":"2005","journal-title":"J Clin Oncol"},{"key":"R31-7-20210131","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1056\/NEJMoa011795","article-title":"CHOP chemotherapy plus rituximab compared with CHOP alone in elderly patients with diffuse large-B-cell lymphoma.","volume":"346","author":"Coiffier","year":"2002","journal-title":"N Engl J Med"},{"key":"R32-7-20210131","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1182\/blood-2005-04-1437","article-title":"Rituximab does not improve clinical outcome in a randomized phase 3 trial of CHOP with or without rituximab in patients with HIV-associated non-Hodgkin lymphoma: AIDS-Malignancies Consortium Trial 010.","volume":"106","author":"Kaplan","year":"2005","journal-title":"Blood"},{"key":"R33-7-20210131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.exphem.2004.12.008","article-title":"HIV-associated lymphoma successfully treated with peripheral blood stem cell transplantation.","volume":"33","author":"Serrano","year":"2005","journal-title":"Exp Hematol"},{"key":"R34-7-20210131","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1182\/blood-2004-04-1532","article-title":"Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas.","volume":"105","author":"Krishnan","year":"2005","journal-title":"Blood"},{"key":"R35-7-20210131","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/S0140-6736(00)02041-9","article-title":"High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma.","volume":"355","author":"Gabarre","year":"2000","journal-title":"Lancet"},{"key":"R36-7-20210131","doi-asserted-by":"crossref","first-page":"4423","DOI":"10.1200\/JCO.2003.06.039","article-title":"High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy.","volume":"21","author":"Re","year":"2003","journal-title":"J Clin Oncol"},{"key":"R37-7-20210131","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkins lymphoma in combination with highly active antiretroviral therapy.","volume":"19","author":"Ratner","year":"2001","journal-title":"J Clin Oncol"},{"key":"R38-7-20210131","doi-asserted-by":"crossref","first-page":"4430","DOI":"10.1200\/JCO.2005.11.973","article-title":"AIDS-related Burkitts lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy.","volume":"23","author":"Lim","year":"2005","journal-title":"J Clin Oncol"},{"key":"R39-7-20210131","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1080\/1042819031000141301","article-title":"Modified Magrath regimens for adults with Burkitt and Burkitt-like lymphomas: preserved efficacy with decreased toxicity.","volume":"45","author":"Lacasce","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R40-7-20210131","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1093\/annonc\/mdf253","article-title":"An international evaluation of CODOX-M and CODOX-M alternating with IVAC in adult Burkitts lymphoma: results of United Kingdom Lymphoma Group LY06 study.","volume":"13","author":"Mead","year":"2002","journal-title":"Ann Oncol"},{"key":"R41-7-20210131","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1200\/JCO.1996.14.3.925","article-title":"Adults and children with small non-cleaved-cell lymphoma have a similar excellent outcome when treated with the same chemotherapy regimen.","volume":"14","author":"Magrath","year":"1996","journal-title":"J Clin Oncol"},{"key":"R42-7-20210131","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1200\/JCO.1999.17.8.2461","article-title":"Hyper-CVAD program in Burkitts-type adult acute lymphoblastic leukemia.","volume":"17","author":"Thomas","year":"1999","journal-title":"J Clin Oncol"},{"key":"R43-7-20210131","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/j.1365-2141.2004.05141.x","article-title":"High response rate and manageable toxicity with an intensive, short-term chemotherapy programme for Burkitts lymphoma in adults.","volume":"126","author":"Di Nicola","year":"2004","journal-title":"Br J Haematol"},{"key":"R44-7-20210131","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/cncr.21776","article-title":"Chemoimmunotherapy with hyper-CVAD plus rituximab for the treatment of adult Burkitt and Burkitt-type lymphoma or acute lymphoblastic leukemia.","volume":"106","author":"Thomas","year":"2006","journal-title":"Cancer"},{"key":"R45-7-20210131","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1002\/cncr.10365","article-title":"Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma\/leukemia.","volume":"94","author":"Cortes","year":"2002","journal-title":"Cancer"},{"key":"R46-7-20210131","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1002\/cncr.11628","article-title":"Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate\/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M\/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma.","volume":"98","author":"Wang","year":"2003","journal-title":"Cancer"},{"key":"R47-7-20210131","first-page":"445","article-title":"Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3\/97 study.","volume":"88","author":"Oriol","year":"2003","journal-title":"Haematologica"},{"key":"R48-7-20210131","first-page":"990","article-title":"Highly active antiretroviral therapy and outcome of AIDS-related Burkitts lymphoma or leukemia. Results of the PETHEMA-LAL3\/97 study.","volume":"90","author":"Oriol","year":"2005","journal-title":"Haematologica"}],"container-title":["JAIDS Journal of Acquired Immune Deficiency Syndromes"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00126334-200702010-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:18:32Z","timestamp":1618039112000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00126334-200702010-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,2,1]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007]]}},"URL":"https:\/\/doi.org\/10.1097\/qai.0b013e31802bb5d0","relation":{},"ISSN":["1525-4135"],"issn-type":[{"value":"1525-4135","type":"print"}],"subject":[],"published":{"date-parts":[[2007,2,1]]}}}